And it seems like the pressure's still on at Allergan, with activist investor David Tepper going after Botox-maker Allergan again this week, calling for the company to split the roles of chairman and CEO. Right now, Brent Saunders serves in both positions. Tepper wrote that separating the roles would be the "first step" to turning Allergan around, my colleague Emma Court reports.